Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton
Recalled May 1, 2024 · FDA recall D-0471-2024 · Cipla USA
Hazard
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch. · FDA Class II
Units
59244/3ml FFS packs
Sold at
USA nationwide.
Description
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Product
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
Manufacturer(s)
Cipla USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →